WHO ICTRP trial
Study on serum CXCL6 as a diagnostic and progression marker for idiopathic…
ChiCTR2400084292 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400084292 |
|---|---|
| Public title | Study on serum CXCL6 as a diagnostic and progression marker for idiopathic pulmonary fibrosis and its related mechanisms |
| Scientific title | Study on serum CXCL6 as a diagnostic and progression marker for idiopathic pulmonary fibrosis and its related mechanisms |
| Primary sponsor | Shanghai Fifth People’s Hospital, Fudan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Basic Science |
| Phase | 0 |
| Countries | China |
| Conditions | idiopathic pulmonary fibrosis |
| Interventions | IPF:None;Normal:None |
| Registration date | May 14, 2024 |
| Target size | IPF:50;Normal:50 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: